Higher efficacy and reduced adverse reactions in neoadjuvant chemotherapy for breast cancer by using pegylated liposomal doxorubicin compared with pirarubicin

The present study aimed to investigate the efficacy and toxicity of pegylated liposomal doxorubicin (PLD) in preoperative neoadjuvant chemotherapy for patients with breast cancer by comparing with conventional anthracycline. This study is a non-randomized controlled trial. Prospective analysis was c...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Weifang, Chen, Wei, Zhang, Xiuxiang, Zhao, Peng, Fan, Zhimin, Bi, Lirong, Wu, Di, Li, Sijie, Yang, Ming, Fu, Tong, Song, Dong, Han, Bing, Zhao, Gang, Du, Ye, Shi, Aiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794400/
https://www.ncbi.nlm.nih.gov/pubmed/33420241
http://dx.doi.org/10.1038/s41598-020-80415-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794400/
https://www.ncbi.nlm.nih.gov/pubmed/33420241
http://dx.doi.org/10.1038/s41598-020-80415-w

Ejemplares similares